AperçuGraphiqueProfilStatistiques clésDonnées financièresActualités
Dérivés
TraderScreen

RECORDATI SPA EO -,125/  IT0003828271  /

Lang & Schwarz
13/11/2024  22:58:51 Chg. +0.95 Volume Bid22:58:51 Demandez à22:58:51 Capitalisation boursière Dividende Y. Rapport P/E
51.80EUR +1.87% -
Chiffrre d'affaires: -		 51.80Bid taille: - 52.25Ask la taille: - 10.69 Mrd.EUR 2.31% 27.42
GlobeNewswire 20/12/2021 CENTOGENE Announces CEO to Take Temporary Medical Leave of Absence – Biopharmaceutical Industry Vete...
GlobeNewswire 20/12/2021 Eton Pharmaceuticals and ANI Pharmaceuticals Announce Commercial Availability of Carglumic Acid Tabl...
GlobeNewswire 23/03/2021 RECORDATI: POSITIVE RESULTS FROM THE PHASE III LINC 4 STUDY PRESENTED AT THE ENDOCRINE SOCIETY’S AN...
GlobeNewswire 22/02/2021 RECORDATI: PRELIMINARY 2020 RESULTS CONFIRM CONTINUED GROWTH OF OPERATING INCOME AND NET INCOME. EBI...
GlobeNewswire 29/01/2021 RECORDATI: LICENSE OBTAINED FOR THE COMMERCIALIZATION OF ELIGARD IN EUROPE AND OTHER COUNTRIES
GlobeNewswire 30/11/2020 RECORDATI: MARKET AUTHORIZATION APPLICATION FOR ARS-1 (EPINEPHRINE NASAL SPRAY) ACCEPTED BY EUROPEA...
GlobeNewswire 05/11/2020 Amryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
GlobeNewswire 29/10/2020 RECORDATI: PROFIT GROWTH IN THE FIRST NINE MONTHS OF 2020. REVENUES -0.6%, EBITDA +7.1%, ADJUSTED NE...
GlobeNewswire 01/10/2020 RECORDATI: MERGER BY ABSORPTION OF FIMEI S.P.A. AND ROSSINI INVESTIMENTI S.P.A. INTO RECORDATI S.P....
GlobeNewswire 21/09/2020 RECORDATI LICENSES AN INNOVATIVE EPINEPHRINE NASAL SPRAY IN DEVELOPMENT FOR ANAPHYLAXIS PREVENTION
GlobeNewswire 06/08/2020 AMRYT ANNOUNCES Q2 2020 RESULTS AND ISSUES POSITIVE REVENUE GUIDANCE FOR FY 2020
GlobeNewswire 30/07/2020 RECORDATI ANNOUNCES POSITIVE FIRST HALF 2020 RESULTS. REVENUES +2.3%, EBITDA +11.4%, ADJUSTED NET IN...
GlobeNewswire 17/06/2020 RECORDATI: ISTURISA® (OSILODROSTAT) PHASE III LINC-4 TRIAL MEETS ITS PRIMARY ENDPOINT IN CUSHING’S D...
GlobeNewswire 14/05/2020 Eton Pharmaceuticals Announces First Quarter 2020 Financial Results
GlobeNewswire 11/05/2020 Amryt Pharma Plc - Q1 2020 RESULTS
GlobeNewswire 11/05/2020 Amryt Pharma Plc - Full Year 2019 RESULTS
GlobeNewswire 07/05/2020 RECORDATI ANNOUNCES GROWTH IN THE FIRST QUARTER 2020. REVENUES +12.1%, EBITDA +20.1%
GlobeNewswire 04/05/2020 Eton Pharmaceuticals Announces Appointment of Paul Stickler as Senior Vice President of Sales and Ma...
GlobeNewswire 29/04/2020 RECORDATI SHAREHOLDERS APPROVE THE 2019 ACCOUNTS. DIVIDEND € 1.00 PER SHARE (+8.7% vs 2018)
GlobeNewswire 08/04/2020 Recordati Rare Diseases now holds Isturisa® European MA
GlobeNewswire 26/03/2020 RECORDATI SUBMITS NEW DRUG APPLICATION FOR ISTURISA® IN JAPAN
GlobeNewswire 18/03/2020 RECORDATI CONTRIBUTES TO SUPPORT HOSPITALS AND PATIENTS IN THE FACE OF THE EPIDEMIOLOGIC EMERGENCY D...
GlobeNewswire 18/03/2020 BOARD APPROVES THE 2019 ACCOUNTS. SALES € 1,481.8 MILLION (+9.6%), EBITDA € 544.0 MILLION (+9.0%). ...
GlobeNewswire 14/02/2020 RECORDATI: PRELIMINARY 2019 RESULTS CONFIRM CONTINUED GROWTH OF SALES AND PROFITS. SALES +9.6%. EBIT...
GlobeNewswire 15/01/2020 RECORDATI: ISTURISA® (OSILODROSTAT) APPROVED